Artículo
Prognostic significance of α- and β2-adrenoceptor gene expression in breast cancer patients
Registro en:
10.1111/bcp.14030
Autor
Rivero, Ezequiel Mariano
Martinez, Leandro Marcelo
Bruque, Carlos David
Gargiulo, Lucia
Bruzzone, Ariana
Lüthy, Isabel Alicia
Resumen
Fil: Rivero, Ezequiel Mariano. Laboratory of Hormones and Cancer, Instituto de Biología y Medicina Experimental (IBYME) - CONICET, Ciudad Autónoma de Buenos Aires; Argentina. Fil: Martinez, Leandro Marcelo. Research Institute, Hospital for Special Surgery, New York; Estados Unidos. Fil: Bruque, Carlos David. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica; Argentina. Fil: Gargiulo, Lucia. Laboratory of Hormones and Cancer, Instituto de Biología y Medicina Experimental (IBYME) - CONICET, Ciudad Autónoma de Buenos Aires; Argentina. Fil: Bruzzone, Ariana. Instituto de Investigaciones Bioquímicas Bahía Blanca INIBIBB-CONICET, Bahía Blanca; Argentina. Fil: Lüthy, Isabel Alicia. Laboratory of Hormones and Cancer, Instituto de Biología y Medicina Experimental (IBYME) - CONICET, Ciudad Autónoma de Buenos Aires; Argentina. Breast cancer is the most frequently diagnosed and leading cause of cancer death among women worldwide. It was classified within molecular intrinsic subtypes: luminal A, luminal B, human epidermal growth factor receptor 2-enriched and basal-like. Epinephrine and norepinephrine, released during stress, bind to adrenoceptors. α2 -adrenoceptors are encoded by the ADRA2A, ADRA2B and ADRA2C genes and β2 by ADRB2.